"Without clinical research trials, many of the lifesaving medications available today simply would not exist. Clinical Trials Research (CTR) is destigmatizing the process for research volunteers, who may fear becoming “Guinea pigs,” by providing individualized care and education along the way and minimizing risk to patients. “The number one concern is do no harm,” said Robyn Lawrie, a nurse practitioner at CTR. “We would never do anything to ever hurt you.” Since 2000, CTR studies have helped approve more than 200 medications with the help of over 1,000 patient volunteers, and the clinic has maintained its reputation for quality care and volunteer attention. Learn more about us by visiting our website at CTR Sites dot com."

During the past decade, Clinical Trials Research conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 30 clinical trials were completed, i.e. on average, 65.2% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 21 clinical trials were completed. i.e. 72.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Trials Research" #1 sponsor was "Pfizer" with 11 trials, followed by "Ionis Pharmaceuticals, Inc." with 4 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 3 trials sponsored, "NewAmsterdam Pharma" with 3 trials sponsored and "Altimmune, Inc." with 3 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Trials Research" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "ICON Clinical Research" with 2 trials as a collaborator, "Camurus AB" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Trials Research" are "Hypertension" (5 trials), "Hot Flashes" (4 trials), "Nonalcoholic Fatty Liver Disease" (4 trials), "Dyslipidemias" (3 trials) and "Hypercholesterolemia" (3 trials). Many other conditions were trialed in "Clinical Trials Research" in a lesser frequency.

Most popular intervention types in "Clinical Trials Research" are "Drug" (55 trials), "Other" (10 trials), "Biological" (3 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "placebo" (4 trials), "PF-05221304" (3 trials), "ALT-801" (2 trials) and "Aprocitentan 25 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Trials Research" are 48 trials for "All" genders, 5 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Trials Research". undefined are not yet recruiting, 8 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in Clinical Trials Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Trials Research, 3 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".